Structural, topological, and functional characterization of transmembrane proteins TMEM213, 207, 116, 72 and 30B provides a potential link to ccRCC etiology

Joanna Wesoly; Natalia Pstrąg; Kamil Derylo; Barbara Michalec-Wawiórka; Natalia Derebecka; Hanna Nowicka; Arkadiusz Kajdasz; Katarzyna Kluzek; Malgorzata Srebniak; Marek Tchórzewski; Zbigniew Kwias; Hans Bluyssen

Structural, topological, and functional characterization of transmembrane proteins TMEM213, 207, 116, 72 and 30B provides a potential link to ccRCC etiology

Am J Cancer Res. 2023 May 15;13(5):1863-1883. eCollection 2023.

Affiliations

¹ Laboratory of High Throughput Technologies, Adam Mickiewicz University Poznan, Poland.
² Department of Molecular Biology, Maria Curie-Sklodowska University Lublin, Poland.
³ Laboratory of Human Molecular Genetics, Adam Mickiewicz University Poznan, Poland.
⁴ Department of Clinical Genetics, Erasmus Medical Center The Netherlands.
⁵ Department of Urology and Urological Oncology, Poznan University of Medical Sciences Poznan, Poland.

PMID: 37293153
PMCID: PMC10244102

Abstract

Due to their involvement in the development of various cancers Transmembrane Proteins (TMEMs) are the focus of many recent studies. Previously we reported TMEM de-regulation in clear cell Renal Cell Carcinoma (ccRCC) with TMEM213, 207, 116, 72 and 30B being among the most downregulated on mRNA level. TMEM down-regulation was also more pronounced in advanced ccRCC tumors and was potentially linked to clinical parameters such as: metastasis (TMEM72 and 116), Fuhrman grade (TMEM30B) and overall survival (TMEM30B). To further investigate these findings, first, we set off to prove experimentally that selected TMEMs are indeed membrane-bound as predicted in silico, we verified the presence of signaling peptides on their N-termini, orientation of TMEMs within the membrane and validated their predicted cellular localization. To investigate the potential role of selected TMEMs in cellular processes overexpression studies in HEK293 and HK-2 cell lines were carried out. Additionally, we tested TMEM isoform expression in ccRCC tumors, identified mutations in TMEM genes and examined chromosomal aberrations in their loci. We confirmed the membrane-bound status of all selected TMEMs, assigned TMEM213, and 207 to early endosomes, TMEM72 to early endosomes and plasma membrane, TMEM116 and 30B to the endoplasmic reticulum. The N-terminus of TMEM213 was found to be exposed to the cytoplasm, the C-terminus of TMEM207, 116 and 72 were directed toward the cytoplasm, and both termini of TMEM30B faced the cytoplasm. Interestingly, TMEM mutations and chromosomal aberrations were infrequent in ccRCC tumors, yet we identified potentially damaging mutations in TMEM213 and TMEM30B and found deletions in the TMEM30B locus in nearly 30% of the tumors. Overexpression studies suggested selected TMEMs may take part in carcinogenesis processes such as cell adhesion, regulation of epithelial cell proliferation, and regulation of adaptive immune response, which could indicate a link to the development and progression of ccRCC.

Keywords: ccRCC; gene expression; subcellular localization; transmembrane protein.